CT 102

Drug Profile

CT 102

Alternative Names: PDWHF; Platelet-derived wound healing formula

Latest Information Update: 27 Nov 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Curative Health Services
  • Class Antihyperglycaemics; Growth factors
  • Mechanism of Action Intercellular signalling peptide and protein stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Diabetic foot ulcer; Skin ulcer

Most Recent Events

  • 27 Nov 1998 No-Development-Reported for Diabetic foot ulcer in Europe (Topical)
  • 27 Nov 1998 No-Development-Reported for Diabetic foot ulcer in USA (Topical)
  • 27 Nov 1998 No-Development-Reported for Skin ulcer (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top